INFLECTION BIOSCIENCES
Inflection Biosciences is an early stage, drug development company with a focus on developing innovative small molecule therapeutics that address major unmet needs in cancer. With bases in Dublin and London, the company is dedicated to identifying excellent early stage cancer research from academic institutes and companies around the world. Inflection Biosciences will use its expertise to progress the most promising programs through pre-clinical and early clinical stages, partnering with la... rger. pharma for later stage clinical development and commercialisation. The company’s founders, including CEO Darren Cunningham and Director of R&D Dr. Michael O’Neill, bring over 60 years of industry experience along with access to a global network of potential partners and service providers.
INFLECTION BIOSCIENCES
Social Links:
Industry:
Biotechnology Life Science Medical Pharmaceutical
Founded:
2012-01-01
Address:
Blackrock, Dublin, Ireland
Country:
Ireland
Website Url:
http://www.inflectionbio.com
Total Employee:
1+
Status:
Active
Contact:
+353 1 400 3615
Email Addresses:
[email protected]
Total Funding:
738.44 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Organization Schema Person Schema Google GStatic Google Static Content
Similar Organizations
Darwin Bioprospecting Excellence
Darwin Bioprospecting Excellence is a company that selects microbial strains for the biotechnology industry.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Panoptes
Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases.
PhotoBiotics
PhotoBiotics is develops targeted therapeutics for MRI imaging and cancer treatment.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Inflection Biosciences
Enterprise Ireland
Enterprise Ireland investment in Seed Round - Inflection Biosciences
Official Site Inspections
http://www.inflectionbio.com Semrush global rank: 6.12 M Semrush visits lastest month: 1.32 K
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Inflection Biosciences"
InflectionBio
Apr 6, 2025 Inflection Biosciences Ltd is an early stage, drug development company with a focus on discovering and developing innovative small molecule therapeutics addressing major …See details»
Inflection Biosciences - Crunchbase Company Profile & Funding
Inflection Biosciences is a company that develops small-molecule therapeutics for the treatment of cancer.See details»
Inflection Biosciences Ltd - LinkedIn
Inflection Biosciences Ltd Biotechnology Research Inflection Biosciences is developing small molecule therapeutics for cancer, autoimmune and inflammatory disease.See details»
Inflection Biosciences - Org Chart, Teams, Culture & Jobs | The Org
View Inflection Biosciences' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Inflection Biosciences 2025 Company Profile: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Inflection Biosciences. Use the PitchBook Platform to explore the full profile.See details»
Inflection Biosciences - Products, Competitors, Financials, …
Aug 28, 2023 Inflection Biosciences is a company that develops small molecule therapeutics for the treatment of cancer, autoimmune, and inflammatory diseases within the biotechnology …See details»
About Us - Inflection Biosciences
Inflection Biosciences's strategy is to find and license the best drug discovery projects from around the world and to progress them through pre-clinical and early clinical stages before …See details»
What We Do - Inflection Biosciences
Inflection Biosciences' research and development activities are focused entirely on cancer. Our pipeline is aimed at developing innovative, targeted small molecule therapeutics which …See details»
Careers - Inflection Biosciences
Inflection Biosciences is an equal opportunities employer and is always interested to hear from exceptional individuals with business development, project management, drug development …See details»
Inflection Biosciences Ltd. (@InflectionBio) / Twitter
Feb 5, 2015 Innovative drug therapies. Focusing on small molecular therapeutics with big impact for patients and investors in cancer, autoimmune and inflammatory diseases.See details»
Inflection Biosciences Ltd | EuroQuity
About your organization / profile Inflection Biosciences Ltd, an award winning biotech ased in Dublin and Boston, is developing small molecule therapeutics for the treatment of cancer. The …See details»
INFLECTION BIOSCIENCES LIMITED - explore.openaire.eu
Organization, country, INFLECTION BIOSCIENCES LIMITEDINFLECTION BIOSCIENCES LIMITEDSee details»
Inflection Biosciences - Company Information, Competitors, News …
Find useful insights on Inflection Biosciences's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Inflection Biosciences.See details»
Inflection Biosciences | VentureRadar
Inflection Biosciences is developing small molecule therapeutics for the treatment of cancer, autoimmune and inflammatory disease. The pipeline comprises of IBL-101, an oral, pan-PIM …See details»
Inflection Biosciences Ltd Company Profile - Powrbot list of …
Company information for Inflection Biosciences Ltd , including website, description, revenue, employees, headquarters, founders and more.See details»
Innoplexus: AI-Powered Life Sciences Solutions
Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence to expedite PIM kinase inhibitor development ESCHBORN, Germany, May 30, 2022 – …See details»
For Employers - Inflection
The global platform for expert education during life’s hardest moments.See details»
Inflection Biosciences Announces Expansion of Research into …
May 27, 2022 Expands Advisory Panel with Immunology and Rheumatology ExpertiseDublin, Ireland, May 27, 2022 Inflection Biosciences Ltd, a company developing innovative …See details»
Technology | Inflection Biosciences
Inflection Biosciences’ dual mechanism cancer drug program is the first of its kind rationally designed to target two well-known cancer pathways, PIM kinase and PI3K. Our first-in-class …See details»
News - Inflection Biosciences
Read about our Press Releases and see where Inflection Biosciences is making News. We also welcome you to join our mailing list to keep in touch with our updates.See details»